Literature DB >> 1451955

Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women.

E B Rimm1, J E Manson, M J Stampfer, G A Colditz, W C Willett, B Rosner, C H Hennekens, F E Speizer.   

Abstract

We examined the association between oral contraceptive use and incidence of Type 2 (non-insulin-dependent) diabetes mellitus among 115117 female nurses free of diabetes, cardiovascular disease and cancer in 1976 and followed-up for 12 years. During 1237440 person years of follow-up, 2276 women who provided information on oral contraceptive use were clinically diagnosed with Type 2 diabetes. Women who used oral contraceptives in the past had only a slight and marginally increased relative risk of 1.10 (95% confidence interval 1.01, 1.21) compared to those women who had never used oral contraceptives after controlling for known risk factors of disease. We found no evidence of increased risk with longer duration of use or with shorter interval since last use. Current users did not have an increased risk of Type 2 diabetes (relative risk = 0.86, 95% confidence interval 0.46, 1.61) when compared to women who had never used the drug. There was no effect modification by obesity, family history of diabetes, or physical activity. These data suggest that past or current oral contraceptive use does not substantially influence subsequent risk of Type 2 diabetes.

Entities:  

Keywords:  Americas; Biology; Contraception; Contraceptive Methods; Delivery Of Health Care; Developed Countries; Diabetes Mellitus; Diseases; Epidemiologic Methods; Family Planning; Health; Health Personnel; Incidence; Measurement; North America; Northern America; Nurses; Oral Contraceptives; Prospective Studies; Research Methodology; Risk Factors; Studies; United States

Mesh:

Substances:

Year:  1992        PMID: 1451955     DOI: 10.1007/bf00401427

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Myocardial infarction in young women with special reference to oral contraceptive practice.

Authors:  J I Mann; M P Vessey; M Thorogood; S R Doll
Journal:  Br Med J       Date:  1975-05-03

2.  Oral contraceptives and diabetes mellitus.

Authors:  P C Hannaford; C R Kay
Journal:  BMJ       Date:  1989-11-25

3.  The ability of women to recall their oral contraceptive histories.

Authors:  A Coulter; M Vessey; K McPherson; B Crossley
Journal:  Contraception       Date:  1986-02       Impact factor: 3.375

4.  Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.

Authors:  J E Manson; E B Rimm; M J Stampfer; G A Colditz; W C Willett; A S Krolewski; B Rosner; C H Hennekens; F E Speizer
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

Review 5.  Carbohydrate metabolism in male infertility and female fertility-control patients.

Authors:  W N Spellacy
Journal:  Fertil Steril       Date:  1976-10       Impact factor: 7.329

6.  Intravenous glucose tolerance after 18 months on progestogen or combination-type oral contraceptive.

Authors:  J A Goldman
Journal:  Isr J Med Sci       Date:  1978-03

7.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

8.  Oral contraceptive use: prospective follow-up of women with suspected glucose intolerance.

Authors:  T J Duffy; R Ray
Journal:  Contraception       Date:  1984-09       Impact factor: 3.375

9.  Oral-contraceptive use in relation to myocardial infarction.

Authors:  S Shapiro; D Slone; L Rosenberg; D W Kaufman; P D Stolley; O S Miettinen
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  13 in total

1.  Approach to the patient with gestational diabetes after delivery.

Authors:  Thomas A Buchanan; Kathleen A Page
Journal:  J Clin Endocrinol Metab       Date:  2011-12       Impact factor: 5.958

2.  Is grand multiparity associated with an increased risk of dysglycaemia?

Authors:  D Simmons; J Shaw; A McKenzie; S Eaton; A J Cameron; P Zimmet
Journal:  Diabetologia       Date:  2006-05-11       Impact factor: 10.122

3.  Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES.

Authors:  Sung-Woo Kim; Jae-Han Jeon; Won-Kee Lee; Sungwoo Lee; Jung-Guk Kim; In-Kyu Lee; Keun-Gyu Park
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

Review 4.  New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.

Authors:  R Taylor; M Vanderpump
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

5.  The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

Authors:  Alexandra Bargiota; Evanthia Diamanti-Kandarakis
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

Review 6.  Oestrogens and insulin secretion.

Authors:  I F Godsland
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

7.  Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses' Health Study, Nurses' Health Study 2, and Health Professionals' Follow-up Study.

Authors:  Andres V Ardisson Korat; Walter C Willett; Frank B Hu
Journal:  Curr Nutr Rep       Date:  2014-12-01

Review 8.  Polycystic ovary syndrome: current status and future perspective.

Authors:  Erin K Barthelmess; Rajesh K Naz
Journal:  Front Biosci (Elite Ed)       Date:  2014-01-01

9.  Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.

Authors:  Alessandra Gambineri; Laura Patton; Paola Altieri; Uberto Pagotto; Carmine Pizzi; Lamberto Manzoli; Renato Pasquali
Journal:  Diabetes       Date:  2012-06-14       Impact factor: 9.461

10.  Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.

Authors:  Robert Root-Bernstein; Abigail Podufaly; Patrick F Dillon
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.